ucb-banks-on-georgia-for-2bn-biologics-manufacturing-facility-shaping-investments-in-united-states
The biopharmaceutical industry is abuzz with the latest announcement from UCB, a global leader in the development and commercialization of innovative treatments, as it sets its sights on Georgia for a whopping $2 billion investment in a state-of-the-art biologics manufacturing facility. This move is poised to not only bolster the company’s presence in the United […]










